IBM and Accelrys in Four-Year Drug Discovery IT Alliance | GenomeWeb

 

NEW YORK, Jan. 7—IBM and Pharmacopeia subsidiary Accelrys have formed a wide-ranging drug discovery hardware and software technology and marketing alliance, the two firms said Monday.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.

An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.

The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.

In Nature this week: genotypes linked to hip osteoarthritis, and more.